FEATURED ARTICLES

Ocugen Chief Medical Officer Huma Qamar, MD, MPH, CMI, discusses two rare disease trials and how the company's managed their protocol design, PI selection, and patient recruitment.
-
Refresh Your CTA Strategy With Cybersecurity And EHRs In Mind, Part One
Leibowitz Law experts examine how tech developments affect key CTA provisions and provide practical, technology-inspired updates for your clinical trial agreements. Part one of this two-part series explores cybersecurity and EHR standards.
-
Are Sites Even Using AI?: How Sponsors And CROs Can Support Uptake
How much are clinical research sites using AI? And how can sponsors and CROs effectively support sites in doing so? Consultant Maria P. Ladd explains.
-
5 Ways AI Is Changing Clinical Research — And How To Embrace It
Discover how AI is transforming clinical trials, learn real tools already in use, and get practical guidance for clinical professionals — especially CRAs and site teams — looking to upskill in an AI-enhanced environment.